小檗碱
安普克
胰腺上皮内瘤变
蛋白激酶A
腺苷
胰腺癌
癌症研究
化学
AMP活化蛋白激酶
糖酵解
药理学
激酶
生物
生物化学
医学
内科学
癌症
新陈代谢
胰腺导管腺癌
作者
Meng-Meng Liu,Yongjie Yang,Wenli Kang,Yingjie Liu,Xufeng Tao,Xiaona Li,Yue Pan
标识
DOI:10.1016/j.ejphar.2021.174680
摘要
Most cases of pancreatic cancer develop in patients with chronic pancreatitis (CP). Berberine is natural product that exhibits anti-tumor effects in various types of cancer and is used in traditional Chinese medicine. In this study, we demonstrated that berberine inhibited the development of pancreatic intraepithelial neoplasia (PanIN) in an in vivo CP model and an in vitro acinar-to-ductal metaplasia model. As berberine may inhibit glycolysis during the development of PanIN, we measured indicators of glycolysis. Quantitative reverse transcription polymerase chain reaction and western blotting assays revealed that berberine activated the adenosine monophosphate-activated protein kinase (AMPK) pathway. This demonstrated that berberine suppressed glycolysis by targeting AMPK, a key metabolic sensor. Furthermore, berberine acted via the AMPK-hypoxia-inducible factor 1 alpha pathway to achieve suppression of PanIN. These findings show that berberine is a potential therapeutic candidate for preventing the progression of CP to PanIN.
科研通智能强力驱动
Strongly Powered by AbleSci AI